Skip to main content
Clinical Trials/ISRCTN16929593
ISRCTN16929593
Completed
未知

A cancer rehabilitation and lymphedema care program for patients with resected advanced head and neck cancer: the prevalence and risk factors for head and neck cancer-related lymphedema and development and testing of an intervention and longitudinal measures of its functional outcomes

Ministry of Science and Technology, Taiwan0 sites80 target enrollmentOctober 18, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Ministry of Science and Technology, Taiwan
Enrollment
80
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 18, 2017
End Date
December 31, 2019
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Ministry of Science and Technology, Taiwan

Eligibility Criteria

Inclusion Criteria

  • 1\. Pathologic confirmation of advanced HNSCC (stage III or IV) and patient awareness of the diagnosis
  • 2\. Receipt of radical surgery and RT or CCRT
  • 3\. Completion of radical surgery and RT or CCRT from 3 months to 5 years in the past
  • 4\. Have HNCRL based on physical examination (Foldi’s Scale score \> stage I)
  • 5\. Currently free of evidence of cancer
  • 6\. Age greater than 20 years and less than 70 years
  • 7\. Karnofsky’s Performance Status Index (KPS) score of 60 or greater
  • 8\. Agreement to participate in the study after explanation of its purposes and procedures

Exclusion Criteria

  • 1\. Unresected head and neck cancer
  • 2\. Actively undergoing chemotherapy or RT
  • 3\. Having metastatic cancer or any other active cancer
  • 4\. Any unstable systemic disease (heart disease, active infection, or other underlying disease)
  • 5\. KPS score of 60 or less
  • 6\. Any condition likely to cause discomfort during the research interview

Outcomes

Primary Outcomes

Not specified

Similar Trials